Literature DB >> 32772175

WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup?

Anthony P Y Liu1, Loudy P Priesterbach-Ackley2, Brent A Orr3, Bryan K Li4,5,6, Brian Gudenas7, Roel E Reddingius8, Mariona Suñol9, Cinzia E Lavarino10, Nagore G Olaciregui10, Vicente Santa-María López11, Michael J Fisher12, Lili-Naz Hazrati13, Eric Bouffet4, Annie Huang4,5,6,14, Giles W Robinson15, Pieter Wesseling2,8, Paul A Northcott7, Amar Gajjar15.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32772175      PMCID: PMC7501206          DOI: 10.1007/s00401-020-02208-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  8 in total

1.  Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.

Authors:  Elke Pfaff; Christian Aichmüller; Martin Sill; Damian Stichel; Matija Snuderl; Matthias A Karajannis; Martin U Schuhmann; Jens Schittenhelm; Martin Hasselblatt; Christian Thomas; Andrey Korshunov; Marina Rhizova; Andrea Wittmann; Anna Kaufhold; Murat Iskar; Petra Ketteler; Dietmar Lohmann; Brent A Orr; David W Ellison; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Andreas von Deimling; Peter Lichter; Marcel Kool; Marc Zapatka; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2019-11-25       Impact factor: 17.088

2.  WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum.

Authors:  Yanxin Pei; Sonja N Brun; Shirley L Markant; William Lento; Paul Gibson; Makoto M Taketo; Marco Giovannini; Richard J Gilbertson; Robert J Wechsler-Reya
Journal:  Development       Date:  2012-03-29       Impact factor: 6.868

3.  Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

Authors:  Anthony P Y Liu; Brian Gudenas; Tong Lin; Brent A Orr; Paul Klimo; Rahul Kumar; Eric Bouffet; Sridharan Gururangan; John R Crawford; Stewart J Kellie; Murali Chintagumpala; Michael J Fisher; Daniel C Bowers; Tim Hassall; Daniel J Indelicato; Arzu Onar-Thomas; David W Ellison; Frederick A Boop; Thomas E Merchant; Giles W Robinson; Paul A Northcott; Amar Gajjar
Journal:  Acta Neuropathol       Date:  2019-12-04       Impact factor: 17.088

Review 4.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

5.  Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.

Authors:  Bryan K Li; Alexandre Vasiljevic; Christelle Dufour; Fupan Yao; Ben L B Ho; Mei Lu; Eugene I Hwang; Sridharan Gururangan; Jordan R Hansford; Maryam Fouladi; Sumihito Nobusawa; Annie Laquerriere; Marie-Bernadette Delisle; Jason Fangusaro; Fabien Forest; Helen Toledano; Palma Solano-Paez; Sarah Leary; Diane Birks; Lindsey M Hoffman; Alexandru Szathmari; Cécile Faure-Conter; Xing Fan; Daniel Catchpoole; Li Zhou; Kris Ann P Schultz; Koichi Ichimura; Guillaume Gauchotte; Nada Jabado; Chris Jones; Delphine Loussouarn; Karima Mokhtari; Audrey Rousseau; David S Ziegler; Shinya Tanaka; Scott L Pomeroy; Amar Gajjar; Vijay Ramaswamy; Cynthia Hawkins; Richard G Grundy; D Ashley Hill; Eric Bouffet; Annie Huang; Anne Jouvet
Journal:  Acta Neuropathol       Date:  2019-12-09       Impact factor: 17.088

6.  Subtypes of medulloblastoma have distinct developmental origins.

Authors:  Paul Gibson; Yiai Tong; Giles Robinson; Margaret C Thompson; D Spencer Currle; Christopher Eden; Tanya A Kranenburg; Twala Hogg; Helen Poppleton; Julie Martin; David Finkelstein; Stanley Pounds; Aaron Weiss; Zoltan Patay; Matthew Scoggins; Robert Ogg; Yanxin Pei; Zeng-Jie Yang; Sonja Brun; Youngsoo Lee; Frederique Zindy; Janet C Lindsey; Makoto M Taketo; Frederick A Boop; Robert A Sanford; Amar Gajjar; Steven C Clifford; Martine F Roussel; Peter J McKinnon; David H Gutmann; David W Ellison; Robert Wechsler-Reya; Richard J Gilbertson
Journal:  Nature       Date:  2010-12-08       Impact factor: 49.962

7.  DNA methylation-based classification of central nervous system tumours.

Authors:  David Capper; David T W Jones; Martin Sill; Volker Hovestadt; Daniel Schrimpf; Dominik Sturm; Christian Koelsche; Felix Sahm; Lukas Chavez; David E Reuss; Annekathrin Kratz; Annika K Wefers; Kristin Huang; Kristian W Pajtler; Leonille Schweizer; Damian Stichel; Adriana Olar; Nils W Engel; Kerstin Lindenberg; Patrick N Harter; Anne K Braczynski; Karl H Plate; Hildegard Dohmen; Boyan K Garvalov; Roland Coras; Annett Hölsken; Ekkehard Hewer; Melanie Bewerunge-Hudler; Matthias Schick; Roger Fischer; Rudi Beschorner; Jens Schittenhelm; Ori Staszewski; Khalida Wani; Pascale Varlet; Melanie Pages; Petra Temming; Dietmar Lohmann; Florian Selt; Hendrik Witt; Till Milde; Olaf Witt; Eleonora Aronica; Felice Giangaspero; Elisabeth Rushing; Wolfram Scheurlen; Christoph Geisenberger; Fausto J Rodriguez; Albert Becker; Matthias Preusser; Christine Haberler; Rolf Bjerkvig; Jane Cryan; Michael Farrell; Martina Deckert; Jürgen Hench; Stephan Frank; Jonathan Serrano; Kasthuri Kannan; Aristotelis Tsirigos; Wolfgang Brück; Silvia Hofer; Stefanie Brehmer; Marcel Seiz-Rosenhagen; Daniel Hänggi; Volkmar Hans; Stephanie Rozsnoki; Jordan R Hansford; Patricia Kohlhof; Bjarne W Kristensen; Matt Lechner; Beatriz Lopes; Christian Mawrin; Ralf Ketter; Andreas Kulozik; Ziad Khatib; Frank Heppner; Arend Koch; Anne Jouvet; Catherine Keohane; Helmut Mühleisen; Wolf Mueller; Ute Pohl; Marco Prinz; Axel Benner; Marc Zapatka; Nicholas G Gottardo; Pablo Hernáiz Driever; Christof M Kramm; Hermann L Müller; Stefan Rutkowski; Katja von Hoff; Michael C Frühwald; Astrid Gnekow; Gudrun Fleischhack; Stephan Tippelt; Gabriele Calaminus; Camelia-Maria Monoranu; Arie Perry; Chris Jones; Thomas S Jacques; Bernhard Radlwimmer; Marco Gessi; Torsten Pietsch; Johannes Schramm; Gabriele Schackert; Manfred Westphal; Guido Reifenberger; Pieter Wesseling; Michael Weller; Vincent Peter Collins; Ingmar Blümcke; Martin Bendszus; Jürgen Debus; Annie Huang; Nada Jabado; Paul A Northcott; Werner Paulus; Amar Gajjar; Giles W Robinson; Michael D Taylor; Zane Jaunmuktane; Marina Ryzhova; Michael Platten; Andreas Unterberg; Wolfgang Wick; Matthias A Karajannis; Michel Mittelbronn; Till Acker; Christian Hartmann; Kenneth Aldape; Ulrich Schüller; Rolf Buslei; Peter Lichter; Marcel Kool; Christel Herold-Mende; David W Ellison; Martin Hasselblatt; Matija Snuderl; Sebastian Brandner; Andrey Korshunov; Andreas von Deimling; Stefan M Pfister
Journal:  Nature       Date:  2018-03-14       Impact factor: 49.962

8.  Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool.

Authors:  L P Priesterbach-Ackley; H B Boldt; J K Petersen; N Bervoets; D Scheie; B P Ulhøi; M Gardberg; T Brännström; S H Torp; E Aronica; B Küsters; W F A den Dunnen; F Y F L de Vos; P Wesseling; W W J de Leng; B W Kristensen
Journal:  Neuropathol Appl Neurobiol       Date:  2020-02-18       Impact factor: 8.090

  8 in total
  4 in total

Review 1.  Histopathology and molecular pathology of pediatric pineal parenchymal tumors.

Authors:  Alexandre Vasiljevic
Journal:  Childs Nerv Syst       Date:  2022-08-16       Impact factor: 1.532

Review 2.  Targeting MYCN in Molecularly Defined Malignant Brain Tumors.

Authors:  Anna Borgenvik; Matko Čančer; Sonja Hutter; Fredrik J Swartling
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

Review 3.  Adult Medulloblastoma: Updates on Current Management and Future Perspectives.

Authors:  Enrico Franceschi; Caterina Giannini; Julia Furtner; Kristian W Pajtler; Sofia Asioli; Raphael Guzman; Clemens Seidel; Lidia Gatto; Peter Hau
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

Review 4.  Pineal Gland Tumors: A Review.

Authors:  Gaia Favero; Francesca Bonomini; Rita Rezzani
Journal:  Cancers (Basel)       Date:  2021-03-27       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.